Overview
- Editors:
-
-
Ned H. C. Hwang
-
University of Miami, Coral Gables, USA
-
Vincent T. Turitto
-
Department of Biomedical Engineering, Memphis State University, Memphis, USA
-
Michael R. T. Yen
-
Department of Biomedical Engineering, Memphis State University, Memphis, USA
Access this book
Other ways to access
Table of contents (22 chapters)
-
Front Matter
Pages i-viii
-
-
-
- Robert S. Reneman, Bea Woldhuis, Mirjam G. A. oude Egbrink, Dick W. Slaaf, Geert Jan Tangelder
Pages 25-40
-
-
-
- Steven M. Slack, Winnie Cui, Vincent T. Turitto
Pages 91-102
-
-
-
- Harry L. Goldsmith, Takeshi Karino
Pages 127-150
-
- Kjell S. Sakariassen, Helge E. Roald, José Aznar Salatti
Pages 151-174
-
- Lina Badimon, Juan Jose Badimon
Pages 175-187
-
-
- F. Javier Teijeira, Adel A. Mikhail
Pages 197-227
-
-
-
- Shi-Kang Wang, Ned H. C. Hwang
Pages 259-298
-
- Klaus Affeld, Klaus Schichl, Andreas Ziemann
Pages 299-324
-
- Manuel Concha, Manuel Anguita, Anastasio Montero, José M. Arizón, Federico Vallés, José M. Latre et al.
Pages 325-343
-
- Jean-Raoul Monties, Patrick Havlik, Thierry Mesana
Pages 345-361
About this book
Advances of cardiovascular engineering prompt one to consider innovative device technology - that is, the development of new replacement heart valves or engineering of a totally implantable energy source for an artificial heart. However, these kinds of advances have often proved unable to achieve a long-lasting benefit as the cardiovascular field has matured so fast. Cardiovascular engineering has matured to the point where a major innovation must not only function, but must continuously function better than existing devices. This is difficult to accomplish in the complex cardiovasculature system, in which energy source, biocompatibility, compliance, and functionality all must be considered. The maturation of the field is evident from the fact that many engineered prosthetic systems perform well - for example, heart valves function for long periods of time, large-vessel vascular grafts are quite adequate, extracorporeal membrane oxygenation has significantly prolonged the feasible length of heart bypass and other surgical operations, and total artificial hearts can be used as a bridge to transplant without serious complications, yet none of these systems is as good as the natural ones it replaces. The reasons for this are many and incompletely understood. The next stage of progress must be better to alterations understandings of the various components of vasculature and their response by our devices, be they at the micro- or macro-circulatory levels, in the blood, or associated with the vascular wall.